SmithRx and Mark Cuban Cost Plus Drug Co. announce $9.5 million in client savings
SmithRx, a transparent and 100% pass-through PBM, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), announced this week that in 6 months, they have saved SmithRx clients more than $9.5 million in the autoimmune category alone.